Stockscreener 앱 받기
29.02
1.53%
-0.45
전일 마감가:
$29.47
열려 있는:
$29.35
하루 거래량:
1.73M
Relative Volume:
0.76
시가총액:
$3.55B
수익:
$59.61M
순이익/손실:
$-262.14M
주가수익비율:
-7.4031
EPS:
-3.92
순현금흐름:
$-247.49M
1주 성능:
-6.99%
1개월 성능:
+23.75%
6개월 성능:
+114.96%
1년 성능:
+136.90%
1일 변동 폭
$28.30
$29.50
1주일 범위
$28.30
$31.77
52주 변동 폭
$11.13
$31.77
Arcutis Biotherapeutics Inc Stock (ARQT) Company Profile
명칭
Arcutis Biotherapeutics Inc
전화
805-418-5006
주소
3027 TOWNSGATE ROAD, WESTLAKE VILLAGE, CA
ARQT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARQT
Arcutis Biotherapeutics Inc
|
29.02 | 3.61B | 59.61M | -262.14M | -247.49M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arcutis Biotherapeutics Inc Stock (ARQT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-25 | 개시 | Goldman | Neutral |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-28 | 개시 | Jefferies | Buy |
| 2024-01-03 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-10-26 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2023-10-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-09-07 | 개시 | Needham | Buy |
| 2022-03-17 | 개시 | Goldman | Buy |
| 2021-06-30 | 개시 | Mizuho | Buy |
| 2021-05-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-09 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-10-08 | 개시 | Truist | Buy |
| 2020-02-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-02-25 | 개시 | Cowen | Outperform |
| 2020-02-25 | 개시 | Goldman | Neutral |
| 2020-02-25 | 개시 | Guggenheim | Buy |
모두보기
Arcutis Biotherapeutics Inc 주식(ARQT)의 최신 뉴스
Tori Spelling Teams Up with Arcutis to Share Her Family’s Eczema Journey - WKEF
Looking Into Arcutis Biotherapeutics Inc's Recent Short Interest - Benzinga
What Makes Arcutis Biotherapeutics, Inc. (ARQT) a Strong Momentum Stock: Buy Now? - sharewise.com
Stempoint Capital LP Sells 334,401 Shares of Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected - simplywall.st
Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri - BioSpace
Arcutis Biotherapeutics Appoints Amit Munshi as New Director - TipRanks
Amit Munshi joins Arcutis board as founder Chaudhuri retires - Investing.com
Arcutis Biotherapeutics Announces Board Changes - TradingView
Amit Munshi joins Arcutis board as founder Chaudhuri retires By Investing.com - Investing.com India
Arcutis strengthens board of directors with new appointment of Amit Munshi - marketscreener.com
Arcutis Strengthens Board of Directors with New Appointment - GlobeNewswire
Arcutis Biotherapeutics | 12/8/25 - Channel 13 Las Vegas News KTNV
Arcutis Biotherapeutics: The Earnings Inflection Has Arrived (ARQT) - Seeking Alpha
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Arcutis Biotherapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
XTX Topco Ltd Reduces Position in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Downgraded to "Buy" Rating by Wall Street Zen - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Reaches New 1-Year HighStill a Buy? - MarketBeat
What risks investors should watch in Arcutis Biotherapeutics Inc. stockRate Cut & Reliable Breakout Forecasts - Newser
Howard Welgus Sells 10,000 Shares of Arcutis Biotherapeutics (NASDAQ:ARQT) Stock - MarketBeat
Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells 1,657 Shares - MarketBeat
Arcutis Biotherapeutics stock hits 52-week high at 31.29 USD - Investing.com
Arcutis Biotherapeutics stock hits 52-week high at 31.29 USD By Investing.com - Investing.com Canada
Insider Sell: Howard Welgus Sells 10,000 Shares of Arcutis Bioth - GuruFocus
Assessing Arcutis Biotherapeutics (ARQT) Valuation After Its Strong 1-Year Share Price Surge - Yahoo Finance
Arcutis Biotherapeutics Insider Sold Shares Worth $302,133, According to a Recent SEC Filing - marketscreener.com
AZN's Baxdrostat Gets FDA Priority Tag for Uncontrolled Hypertension - Finviz
Is the Options Market Predicting a Spike in Arcutis Biotherapeutics Stock? - sharewise.com
Arcutis Biotherapeutics: Behind The Big Rally (NASDAQ:ARQT) - Seeking Alpha
(ARQT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
American Century Companies Inc. Purchases 71,815 Shares of Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics Inc (ARQT) Stock Price, Trades & News - GuruFocus
Arcutis Biotherapeutics, Inc. $ARQT is Tejara Capital Ltd's 2nd Largest Position - MarketBeat
Mizuho Maintains Arcutis Biotherapeutics (ARQT) Outperform Recommendation - Nasdaq
Mizuho raises Arcutis Biotherapeutics stock price target on strong Zoryve sales By Investing.com - Investing.com South Africa
Mizuho raises Arcutis Biotherapeutics stock price target on strong Zoryve sales - Investing.com Nigeria
Mizuho Raises Price Target on Arcutis Biotherapeutics (ARQT) to $37 | ARQT Stock News - GuruFocus
Geode Capital Management LLC Has $36.21 Million Stake in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Franklin Resources Inc. Sells 28,990 Shares of Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
DNB Asset Management AS Buys Shares of 28,171 Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Arcutis Biotherapeutics Surges 112% in 2025 Is the Rally Justified After Regulatory Milestones? - Yahoo Finance
Arcutis Biotherapeutics stock reaches 52-week high at 31.1 USD By Investing.com - Investing.com Australia
Arcutis Biotherapeutics stock reaches 52-week high at 31.1 USD - Investing.com
Arcutis Biotherapeutics (ARQT) Is Up 12.6% After FDA Accepts ZORYVE sNDA for Pediatric Psoriasis Review - Yahoo Finance
Intech Investment Management LLC Has $1.21 Million Stock Position in Arcutis Biotherapeutics, Inc. $ARQT - MarketBeat
Why Shares in Arcutis Biotherapeutics Surged Again This Week - AOL.com
Arcutis Biotherapeutics director Lin sells $777,955 in shares By Investing.com - Investing.com UK
Arcutis Biotherapeutics director Lin sells $777,955 in shares - Investing.com
Arcutis Biotherapeutics Director Sells Shares - TradingView
Dir Lin Sells 25,272 ($778K) Of Arcutis Biotherapeutics Inc [ARQT] - TradingView
Arcutis Biotherapeutics Inc (ARQT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):